Smadar Shakked Samira
Keine laufenden Positionen mehr
Karriereverlauf von Smadar Shakked Samira
Ehemalige bekannte Positionen von Smadar Shakked Samira
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Finanzdirektor/CFO | 01.01.1997 | 01.05.2011 |
Ausbildung von Smadar Shakked Samira
| Tel-Aviv University | Masters Business Admin |
| The Hebrew University of Jerusalem | Undergraduate Degree |
Statistik
International
| Israel | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Börse
- Insiders
- Smadar Shakked Samira
- Erfahrung
